Cogent Biosciences (COGT) EBIT Margin (2017 - 2020)
Cogent Biosciences (COGT) recorded quarterly EBIT Margin of 18333.01% in Q3 2020, down 1207.56% quarter-over-quarter from 1402.08% in Q2 2020, and down 1715301.0% on a YoY basis from N/an in Q4 2019.
Cogent Biosciences (COGT) EBIT Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences' EBIT Margin history runs 4 years deep, the most recent figure standing at 18333.01% for Q3 2020.
- In Q3 2020, EBIT Margin fell 1715301.0% year-over-year to 18333.01%; the TTM figure through Dec 2020 stood at 1044.33% (down 90131.0% YoY), while the FY2020 annual figure was 1044.33%, down 90131.0% from the prior year.
- EBIT Margin was 18333.01% for Q3 2020 at Cogent Biosciences, down from 1402.08% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 14.65% in Q4 2019 to a low of 18333.01% in Q3 2020.
- Historically, EBIT Margin has averaged 1640.08% across 4 years, with a median of 332.18% in 2017.
- Biggest YoY gain for EBIT Margin was 30051 bps in 2020; the steepest drop was 1715301 bps in 2020.
- A 4-year view of EBIT Margin shows it stood at 324.07% in 2017, then gained by 27 bps to 236.64% in 2018, then jumped by 106 bps to 14.65% in 2019, then sank by 125223 bps to 18333.01% in 2020.
- The last three EBIT Margin figures came in at 18333.01% (Q3 2020), 1402.08% (Q2 2020), and 87.34% (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Cogent Biosciences | 5.09 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -18,333.01% |
| Jun 30, 2020 | -1,402.08% |
| Mar 31, 2020 | -87.34% |
| Dec 31, 2019 | 14.65% |
| Sep 30, 2019 | -1,180.00% |
| Jun 30, 2019 | -335.91% |
| Mar 31, 2019 | -387.85% |
| Dec 31, 2018 | -236.64% |
| Sep 30, 2018 | -517.67% |
| Jun 30, 2018 | -566.57% |
| Mar 31, 2018 | -314.68% |
| Dec 31, 2017 | -324.07% |
| Sep 30, 2017 | -307.59% |
| Jun 30, 2017 | -290.19% |
| Mar 31, 2017 | -332.18% |